BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11906442)

  • 1. Prophylactic surgery to reduce breast cancer risk: a brief literature review.
    Anderson BO
    Breast J; 2001; 7(5):321-30. PubMed ID: 11906442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic mastectomy for the prevention of breast cancer.
    Lostumbo L; Carbine N; Wallace J; Ezzo J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic bilateral mastectomy and contralateral prophylactic mastectomy.
    Chagpar AB
    Surg Oncol Clin N Am; 2014 Jul; 23(3):423-30. PubMed ID: 24882342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
    Isern AE; Tengrup I; Loman N; Olsson H; Ringberg A
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1177-87. PubMed ID: 17938010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues of regret in women with contralateral prophylactic mastectomies.
    Montgomery LL; Tran KN; Heelan MC; Van Zee KJ; Massie MJ; Payne DK; Borgen PI
    Ann Surg Oncol; 1999 Sep; 6(6):546-52. PubMed ID: 10493622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy.
    Frost MH; Schaid DJ; Sellers TA; Slezak JM; Arnold PG; Woods JE; Petty PM; Johnson JL; Sitta DL; McDonnell SK; Rummans TA; Jenkins RB; Sloan JA; Hartmann LC
    JAMA; 2000 Jul; 284(3):319-24. PubMed ID: 10891963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
    J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of and satisfaction with bilateral prophylactic mastectomy.
    Stefanek ME; Helzlsouer KJ; Wilcox PM; Houn F
    Prev Med; 1995 Jul; 24(4):412-9. PubMed ID: 7479633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic mastectomy: indications, options, and reconstructive alternatives.
    Spear SL; Carter ME; Schwarz K
    Plast Reconstr Surg; 2005 Mar; 115(3):891-909. PubMed ID: 15731693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of prophylactic mastectomy.
    Ghosh K; Hartmann LC
    Oncology (Williston Park); 2002 Oct; 16(10):1319-25; discussion 1325, 1329-30, 1332. PubMed ID: 12435203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preserving choice in breast cancer treatment: A different perspective on contralateral prophylactic mastectomy.
    Pender K; Dodge D; Collins JM
    Womens Health (Lond); 2023; 19():17455057231175812. PubMed ID: 37218720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: a descriptive study.
    Metcalfe KA; Semple JL; Narod SA
    Plast Reconstr Surg; 2004 Aug; 114(2):360-6. PubMed ID: 15277800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy.
    Metcalfe KA; Narod SA
    J Natl Cancer Inst; 2002 Oct; 94(20):1564-9. PubMed ID: 12381709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer.
    McDonnell SK; Schaid DJ; Myers JL; Grant CS; Donohue JH; Woods JE; Frost MH; Johnson JL; Sitta DL; Slezak JM; Crotty TB; Jenkins RB; Sellers TA; Hartmann LC
    J Clin Oncol; 2001 Oct; 19(19):3938-43. PubMed ID: 11579114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contralateral prophylactic mastectomy in women with breast cancer without a family history or genetic predisposition : Consensus statement from the Austrian Gynecologic Oncology Working Group of the Austrian Society of Obstetrics and Gynecology.
    Bjelic-Radisic V; Singer C; Tamussino K; Kölbl H; Petru E; Volgger B; Polterauer S; Oppelt P; Sevelda P; Bogner G; Marth C;
    Wien Klin Wochenschr; 2019 May; 131(9-10):233-236. PubMed ID: 30887224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic mastectomy: who needs it, when and why.
    Burke EE; Portschy PR; Tuttle TM
    J Surg Oncol; 2015 Jan; 111(1):91-5. PubMed ID: 24965368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer.
    Eisen A; Rebbeck TR; Wood WC; Weber BL
    J Clin Oncol; 2000 May; 18(9):1980-95. PubMed ID: 10784640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-reducing mastectomy.
    Edlich RF; Winters KL; Faulkner BC; Lin KY
    J Long Term Eff Med Implants; 2006; 16(4):301-14. PubMed ID: 17073572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological reactions to prophylactic mastectomy synchronous with contralateral breast reconstruction.
    Goin MK; Goin JM
    Plast Reconstr Surg; 1982 Sep; 70(3):355-9. PubMed ID: 7111487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The psychosocial impact of contralateral risk reducing mastectomy (CRRM) on women: A rapid review.
    Collins K; Gee M; Clack A; Wyld L
    Psychooncology; 2018 Jan; 27(1):43-52. PubMed ID: 28453892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.